(0.13%) 5 024.72 points
(0.20%) 37 981 points
(0.32%) 15 655 points
(0.14%) $79.11
(3.31%) $1.996
(-0.35%) $2 303.00
(-0.24%) $26.69
(0.10%) $955.85
(0.39%) $0.937
(0.54%) $11.09
(0.38%) $0.802
(-1.20%) $92.14
0.20% $ 56.11
Live Chart Being Loaded With Signals
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 97 829.00 |
Średni wolumen | 2.76M |
Kapitalizacja rynkowa | 10.15B |
EPS | $0 ( 2024-02-09 ) |
Następna data zysków | ( $0.240 ) 2024-06-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.81 |
ATR14 | $0.0410 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Gunther Scott | Sell | 387 | Common Stock |
2024-01-25 | Kreuzburg Christa | Sell | 523 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 6 071 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 3 981 | Options to purchase Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 1 837 | Common Stock |
INSIDER POWER |
---|
71.17 |
Last 95 transactions |
Buy: 320 499 | Sell: 54 379 |
Wolumen Korelacja
Catalent Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
HXL | 0.925 |
SSTK | 0.923 |
PNR | 0.912 |
HOV | 0.91 |
BWA | 0.91 |
BH | 0.907 |
GTES | 0.906 |
MWA | 0.906 |
ATI | 0.902 |
ESAB | 0.901 |
10 Najbardziej negatywne korelacje | |
---|---|
JE | -0.922 |
CALX | -0.905 |
FSLF | -0.89 |
FAII | -0.874 |
EVTL | -0.867 |
JNJ | -0.865 |
AC | -0.863 |
AFI | -0.863 |
GRUB | -0.859 |
CHGG | -0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Catalent Inc Korelacja - Waluta/Towar
Catalent Inc Finanse
Annual | 2023 |
Przychody: | $4.28B |
Zysk brutto: | $1.06B (24.79 %) |
EPS: | $-1.280 |
FY | 2023 |
Przychody: | $4.28B |
Zysk brutto: | $1.06B (24.79 %) |
EPS: | $-1.280 |
FY | 2022 |
Przychody: | $4.83B |
Zysk brutto: | $1.64B (33.97 %) |
EPS: | $2.74 |
FY | 2021 |
Przychody: | $4.00B |
Zysk brutto: | $1.35B (33.82 %) |
EPS: | $3.15 |
Financial Reports:
No articles found.
Catalent Inc
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej